Vaccine Information Statements

Japanese-language VISs

Up-to-date translations

Out-of-date translations

The translations for
some VISs on our website are from previously published English-language
versions that have since been updated. Unfortunately, IAC is not always
able to obtain translations as updates are issued. Please ensure that your
patients receive information consistent with the current of
the following VISs.

The latest edition of the Hib VIS incorporates CDC's updated format for VISs (Hib VIS was last published in 1998).
The Hib VIS contains a change in the adverse events section ("problems that can happen after any vaccine"), it is advisable to begin using the updated VIS immediately.

CDC added recommending vaccination of children aged 24-59 months and their contacts.

•

Section 3: CDC added to the list of people at high risk for complications from influenza, "People with certain muscle or nerve disorders (such as seizure disorders or severe cerebral palsy) that can lead to breathing or swallowing disorders."

Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions.

•

The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately.

This edition does not differ significantly from the previous edition, particularly with regard to contraindications and
adverse events. CDC encourages use of a new VIS upon publication; however, existing stocks of the previous edition may be
used up.

This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.